HSIL.BO · BSE
Hemant Surgical Industries Lim
₹498
+20.00% (+₹83)
Prev. close
₹415
Volume
2
As of
BSE · may be slightly delayed · 15:04 IST
Price history
No analyst calls on this stock in the last 90 days yet.
Explore by date range →Analyst opinions
Fundamentals
About Hemant Surgical Industries Lim
Hemant Surgical Industries Limited manufactures, markets, imports, and exports surgical products, healthcare products & medical equipment and pharmaceutical products in India and internationally. The company offers healthcare & surgical disposables, includes jms meditape, infusion sets, scap vein set, blood transfusion set, pediatric iv, burette set, safecath silicone foley catheter, endotracheal tube, latex foley catheter, feather skin grafting blade, aero skin stapler, aero plus ecg electrodes, digital thermometer, nebulizer, and oxygen concentrator; and dialysis products, such as dialysis machine, refurbish dialysis machine, heparin, diaclean, citro h, iron sucrose injection, dialyzer, bicart, bibag, bloodline tubing, infusion set, bicarbonate mixture, ro plant, water tank, dialysis bed, dialysis chair, refurb ng dialysis machine, av fistula, on & off kit, lumen catheter, and hemodialysis concentrator. The company also offers radiology & criticare products, such as ultrasouch machine, digital radiography machine, X-ray machine, anesthesia machine, multipara monitor, ecg machine, defibrillator, and icu ventilator; and opthalmology products, including galilean and prismatic loupe, spot illuminator, surgical camera, ttl loupe, light source, slit lamp microscope, and operating microscope. In addition, the company offers surgical disposables, such as meditapes, intravenous infusion sets, and oximeters. Further, it provides a turnkey dialysis center, imaging and diagnostic center, modular intensive care unit, modular operation theater, oncology labs and treatment centers, blood bank, and dental clinic setup services. Hemant Surgical Industries Limited was founded in 1985 and is headquartered in Mumbai, India.
Details
Sector
Healthcare
Industry
Medical Devices
CEO
Mr. Hanskumar Shamji Shah
Headquarters
Mumbai
Employees
109
Website
hemantsurgical.comExchange
View on BSE ↗Key stats
Market cap
₹603.31 Cr
P/E ratio (TTM)
27.8
EPS (TTM)
₹14.94
Beta (1Y · daily vs NIFTY 50)
0.74
Beta (5Y · monthly vs NIFTY 50)
0.17
Shares float
44.67 L
Financial Performance
01 · Financials
FY23 growth needs FY22 filings, which the data source doesn't provide.
02 · Earnings Per Share (EPS)
04 · Operating Efficiency (Growth Rates)
Balance-sheet-based · pre-FY23 not filed in verifiable form
05 · Capital Structure & Asset Utilization
Pre-FY23 not filed in verifiable form
Asset turnover needs a prior year of assets — omitted for the earliest available year.
06 · Asset Base Composition
Pre-FY23 not filed in verifiable form
07 · Debt Level & Coverage
Pre-FY23 not filed in verifiable form
08 · Profit & Loss
Annual
| Line item | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| — | ₹109.15 Cr | ₹105.61 Cr | ₹106.64 Cr | ₹231.81 Cr | |
| EBITDA | — | ₹12.90 Cr | ₹14.78 Cr | ₹14.10 Cr | ₹29.09 Cr |
| — | ₹7.64 Cr | ₹9.80 Cr | ₹8.04 Cr | ₹18.19 Cr | |
| Diluted EPS | ₹4.42 | ₹7.32 | ₹9.85 | ₹7.7 | ₹14.94 |
Revenue, Total expenses (as filed), Employee benefit expense, Depreciation & amortisation, Other expenses, EBITDA, Net income, Pretax income, Tax provision, Interest expense have filed figures for only some of the years shown — the missing years are left blank rather than estimated.
09 · Balance Sheet
Annual
| Line item | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|
| ₹64.69 Cr | ₹96.64 Cr | ₹148.31 Cr | ₹274.26 Cr | |
| ₹7.12 Cr | ₹6.75 Cr | ₹31.03 Cr | ₹49.66 Cr | |
| Stockholders' equity | ₹23.36 Cr | ₹54.86 Cr | ₹63.17 Cr | ₹137.64 Cr |
Annual only — the data source doesn’t publish quarterly balance-sheet detail for most NSE-listed companies.
10 · Cash Flow Statement
Annual
| Line item | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|
| ₹6.30 Cr | ₹-7.56 Cr | ₹4.63 Cr | ₹-32.04 Cr | |
| Investing cash flow | ₹-2.97 Cr | ₹-8.97 Cr | ₹-30.28 Cr | ₹-2.97 Cr |
| Financing cash flow | ₹-69.86 L | ₹21.24 Cr | ₹21.85 Cr | ₹69.31 Cr |
| Capital expenditure | ₹-3.93 Cr | ₹-5.52 Cr | ₹-37.57 Cr | ₹-9.39 Cr |
| End cash position | ₹8.46 Cr | ₹13.17 Cr | ₹9.55 Cr | ₹43.84 Cr |
Annual only — the data source has no quarterly cash-flow-statement coverage.
12 · Peer Comparison
Healthcare
| Company | ||||||||
|---|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | ₹4.48 L Cr | ₹1,837.3 | 37.0 | 5.36 | 13.7% | 0.06 | +11.9% | +11.4% |
| Divi's Laboratories Limited | ₹2.47 L Cr | ₹9,375 | 83.3 | 14.77 | 15.3% | 0.00 | +12.3% | +53.4% |
| Torrent Pharmaceuticals Limited | ₹1.83 L Cr | ₹4,875 | 76.9 | 21.82 | 25.8% | 1.79 | +21.5% | +37.4% |
| Apollo Hospitals Enterprise Limited | ₹1.26 L Cr | ₹8,944.5 | 60.4 | 13.30 | 20.5% | 0.90 | +15.7% | +13.9% |
| Lenskart Solutions Limited | ₹1.18 L Cr | ₹707.2 | 179.9 | 13.48 | 5.6% | 0.35 | +35.4% | — |
| Zydus Lifesciences Limited | ₹1.13 L Cr | ₹1,160 | 25.3 | 4.18 | 18.6% | 0.46 | +18.4% | +10.7% |
| Cipla Limited | ₹1.10 L Cr | ₹1,376.3 | 32.5 | 3.19 | 11.3% | 0.02 | +2.1% | -11.8% |
| Laurus Labs Limited | ₹1.05 L Cr | ₹1,954 | 96.4 | 19.86 | 16.8% | 0.48 | +22.0% | +111.6% |
| Max Healthcare Institute Limited | ₹1.01 L Cr | ₹1,049.3 | 69.8 | 9.39 | 13.4% | 0.32 | +19.0% | -10.6% |
| Dr. Reddy's Laboratories Limited | ₹97,876.16 Cr | ₹1,185 | 29.6 | 2.60 | 11.4% | 0.21 | +3.2% | -10.4% |
| Manipal Health Enterprises Limited | ₹97,364.22 Cr | ₹738.95 | 146.6 | 11.56 | 7.8% | 1.53 | +18.0% | — |
| Hemant Surgical Industries Lim | ₹617.12 Cr | ₹424.5 | 28.4 | 4.48 | 13.2% | 0.36 | +119.2% | +15.6% |
Ranked by market cap within Healthcare, same metrics as the Fundamentals screener. Click a column to sort.
Documents
Annual reports
Official documents linked from their sources — offer documents as filed with SEBI (sebi.gov.in), annual reports and earnings-call transcripts as published on BSE (bseindia.com) and NSE (nseindia.com). Links open the source's own hosting; nothing is re-hosted here.